Monday, November 9, 2026

USD/EUR Jumps By 1% In The Last 5 Sessions

USD/EUR Jumps By 1% In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.53% for the last 5 sessions. At 04:06 EST on Tuesday, 25 July, USD/EUR (USDEUR) is $0.90.

USD/EUR's yearly highs and lows, it's 1.906% up from its 52-week low and 13.776% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy technical analysis: central bank policies determine the fate - 24 July 2023. According to DailyForex on Monday, 24 July, "Last week's trading was generally bullish for the performance of the USD/JPY currency pair, with bullish retracement gains that reached the 141.95 resistance level, and Friday's trading session was the most prominent in the upward retracement path. ", "According to the fundamental analysis, the USD/JPY currency pair is trading affected by the results of the recent economic data, as the Japanese National Consumer Price Index for June missed the expected change (yearly) by 3.5% with a change of 3.3%. "
  • Usd/jpy price analysis: subdued around 141.00 amidst technical indicators turning bearish. According to FXStreet on Monday, 24 July, "if USD/JPY breaks above 142.00, the next resistance will emerge at the top of the Ichimoku Cloud (Kumo) at around 142.80/95, ahead of challenging 143.00.", "On the flip side, and the USD/JPY path of least resistance if prices stay below 142.00, the first support would be the Kijun-Sen at 141.15. "
  • Usd/jpy: more verbal intervention if the bounce accelerates toward 145 – socgen. According to FXStreet on Monday, 24 July, "Economists at Société Générale analyze USD/JPY outlook ahead of the BoJ meeting.", "It would be an almighty surprise if they tweaked the band and would trigger a seismic retracement in USD/JPY and other JPY crosses considering the shifts last week. "
  • Usd/jpy May turn lower in the event boj surprises on Friday – OCBC. According to FXStreet on Monday, 24 July, "In the event BoJ surprises on Friday, then we may see USD/JPY turn lower as markets may be caught wrongfooted."
  • Usd/jpy pulls back from two-week high, trades with modest losses below mid-141.00s. According to FXStreet on Monday, 24 July, "Moreover, doubts that the Fed will commit to a more dovish policy stance assist the buck to preserve its recovery gains from the lowest level since April 2022 touched last week and should lend support to the USD/JPY pair.", "This revives hopes that the BoJ might tweak its Yield Curve Control (YCC) policy later this week, which, along with a softer risk tone, underpins the safe-haven JPY and act as a headwind for the USD/JPY pair."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com